LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 66.67 | 27.76 | 309 | 6695 | 0.0461 | 0.3559 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 66.67 | 27.76 | 3010 | 6695 | 0.4495 | 0.8078 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 68.37 | 27.76 | 584 | 6879 | 0.0849 | 0.4667 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 68.37 | 27.76 | 3019 | 6879 | 0.4389 | 0.8033 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 68.37 | 27.76 | 371 | 6879 | 0.0539 | 0.3854 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 68.37 | 27.76 | 3169 | 6879 | 0.4607 | 0.8143 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.08 | 27.76 | 597 | 6849 | 0.0872 | 0.4712 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.08 | 27.76 | 3128 | 6849 | 0.4567 | 0.8122 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.08 | 27.76 | 401 | 6849 | 0.0585 | 0.3994 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.08 | 27.76 | 3260 | 6849 | 0.4759 | 0.8216 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 71.78 | 27.76 | 554 | 6893 | 0.0804 | 0.4568 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 71.78 | 27.76 | 3278 | 6893 | 0.4756 | 0.8216 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 71.78 | 27.76 | 416 | 6893 | 0.0604 | 0.4053 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 71.78 | 27.76 | 3416 | 6893 | 0.4956 | 0.8311 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 73.48 | 27.76 | 616 | 6957 | 0.0885 | 0.4754 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 73.48 | 27.76 | 3393 | 6957 | 0.4877 | 0.8277 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 73.48 | 27.76 | 462 | 6957 | 0.0664 | 0.4231 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 73.48 | 27.76 | 3576 | 6957 | 0.5140 | 0.8398 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 75.19 | 27.76 | 582 | 7015 | 0.0830 | 0.4641 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 75.19 | 27.76 | 3500 | 7015 | 0.4989 | 0.8331 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 75.19 | 27.76 | 479 | 7015 | 0.0683 | 0.4288 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 75.19 | 27.76 | 3672 | 7015 | 0.5234 | 0.8442 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.89 | 27.76 | 597 | 7025 | 0.0850 | 0.4687 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.89 | 27.76 | 3619 | 7025 | 0.5151 | 0.8406 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.89 | 27.76 | 528 | 7025 | 0.0752 | 0.4462 | MN20160318_Q01 | L15 |